$ALGS Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Aligos Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Aligos Therapeutics, Inc.. Get notifications about new insider transactions in Aligos Therapeutics, Inc. for free.
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 28 2021 | ALGS | Aligos Therapeutic ... | Woiwode Thomas | Director | Buy | J | 0.00 | 2,226 | 0 | 2,226 | 0 to 2.2 K |
| Apr 28 2021 | ALGS | Aligos Therapeutic ... | Woiwode Thomas | Director | Sell | J | 0.00 | 8,385 | 0 | 0 | 8.4 K to 0 (-100.00 %) |
| Apr 28 2021 | ALGS | Aligos Therapeutic ... | Woiwode Thomas | Director | Buy | J | 0.00 | 8,385 | 0 | 8,385 | 0 to 8.4 K |
| Apr 28 2021 | ALGS | Aligos Therapeutic ... | Woiwode Thomas | Director | Sell | J | 0.00 | 9,720 | 0 | 0 | 9.7 K to 0 (-100.00 %) |
| Apr 28 2021 | ALGS | Aligos Therapeutic ... | Woiwode Thomas | Director | Buy | J | 0.00 | 9,720 | 0 | 9,720 | 0 to 9.7 K |
| Apr 28 2021 | ALGS | Aligos Therapeutic ... | Woiwode Thomas | Director | Sell | J | 0.00 | 485,979 | 0 | 1,943,916 | 2.4 M to 1.9 M (-20.00 %) |
| Apr 27 2021 | ALGS | Aligos Therapeutic ... | Scopa James Paul | Director | Option Exercise | A | 29.10 | 30,000 | 873,000 | 30,000 | |
| Oct 22 2020 | ALGS | Aligos Therapeutic ... | Novo Holdings A/S | 10% Owner | Option Exercise | C | 0.00 | 241,219 | 0 | 0 | |
| Oct 22 2020 | ALGS | Aligos Therapeutic ... | Novo Holdings A/S | 10% Owner | Option Exercise | C | 0.00 | 563,851 | 0 | 0 | |
| Oct 22 2020 | ALGS | Aligos Therapeutic ... | Novo Holdings A/S | 10% Owner | Option Exercise | C | 0.00 | 1,609,493 | 0 | 0 | |
| Oct 22 2020 | ALGS | Aligos Therapeutic ... | Novo Holdings A/S | 10% Owner | Buy | P | 15.00 | 200,000 | 3,000,000 | 2,614,563 | 2.4 M to 2.6 M (+8.28 %) |
| Oct 22 2020 | ALGS | Aligos Therapeutic ... | Novo Holdings A/S | 10% Owner | Buy | C | 0.00 | 2,414,563 | 0 | 2,414,563 | 0 to 2.4 M |
| Oct 22 2020 | ALGS | Aligos Therapeutic ... | Wellington Biomedical Innovati ... | 10% Owner | Option Exercise | C | 0.00 | 571,143 | 0 | 0 | |
| Oct 22 2020 | ALGS | Aligos Therapeutic ... | Wellington Biomedical Innovati ... | 10% Owner | Option Exercise | C | 0.00 | 1,335,048 | 0 | 0 | |
| Oct 22 2020 | ALGS | Aligos Therapeutic ... | Wellington Biomedical Innovati ... | 10% Owner | Buy | C | 0.00 | 571,143 | 0 | 1,906,191 | 1.3 M to 1.9 M (+42.78 %) |
| Oct 22 2020 | ALGS | Aligos Therapeutic ... | Wellington Biomedical Innovati ... | 10% Owner | Buy | C | 0.00 | 1,335,048 | 0 | 1,335,048 | 0 to 1.3 M |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | Woiwode Thomas | Director | Option Exercise | C | 0.00 | 198,485 | 0 | 0 | |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | Woiwode Thomas | Director | Option Exercise | C | 0.00 | 85,065 | 0 | 0 | |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | Woiwode Thomas | Director | Option Exercise | C | 0.00 | 463,959 | 0 | 0 | |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | Woiwode Thomas | Director | Option Exercise | C | 0.00 | 198,839 | 0 | 0 | |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | Woiwode Thomas | Director | Option Exercise | C | 0.00 | 2,145,991 | 0 | 0 | |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | Woiwode Thomas | Director | Buy | P | 15.00 | 200,000 | 3,000,000 | 862,444 | 662.4 K to 862.4 K (+30.19 %) |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | Woiwode Thomas | Director | Buy | C | 0.00 | 198,485 | 0 | 662,444 | 464 K to 662.4 K (+42.78 %) |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | Woiwode Thomas | Director | Buy | C | 0.00 | 463,959 | 0 | 463,959 | 0 to 464 K |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | Woiwode Thomas | Director | Buy | C | 0.00 | 85,065 | 0 | 2,429,895 | 2.3 M to 2.4 M (+3.63 %) |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | Woiwode Thomas | Director | Buy | C | 0.00 | 198,839 | 0 | 2,344,830 | 2.1 M to 2.3 M (+9.27 %) |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | Woiwode Thomas | Director | Buy | C | 0.00 | 2,145,991 | 0 | 2,145,991 | 0 to 2.1 M |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | Vivo Capital VIII, LLC | 10% Owner | Option Exercise | C | 0.00 | 30,939 | 0 | 0 | |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | Vivo Capital VIII, LLC | 10% Owner | Option Exercise | C | 0.00 | 224,054 | 0 | 0 | |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | Vivo Capital VIII, LLC | 10% Owner | Option Exercise | C | 0.00 | 72,320 | 0 | 0 | |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | Vivo Capital VIII, LLC | 10% Owner | Option Exercise | C | 0.00 | 523,726 | 0 | 0 | |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | Vivo Capital VIII, LLC | 10% Owner | Option Exercise | C | 0.00 | 260,380 | 0 | 0 | |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | Vivo Capital VIII, LLC | 10% Owner | Option Exercise | C | 0.00 | 1,885,611 | 0 | 0 | |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | Vivo Capital VIII, LLC | 10% Owner | Buy | P | 15.00 | 66,733 | 1,000,995 | 430,372 | 363.6 K to 430.4 K (+18.35 %) |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | Vivo Capital VIII, LLC | 10% Owner | Buy | P | 15.00 | 483,267 | 7,249,005 | 3,116,658 | 2.6 M to 3.1 M (+18.35 %) |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | Vivo Capital VIII, LLC | 10% Owner | Buy | C | 0.00 | 30,939 | 0 | 363,639 | 332.7 K to 363.6 K (+9.30 %) |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | Vivo Capital VIII, LLC | 10% Owner | Buy | C | 0.00 | 72,320 | 0 | 332,700 | 260.4 K to 332.7 K (+27.77 %) |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | Vivo Capital VIII, LLC | 10% Owner | Buy | C | 0.00 | 260,380 | 0 | 260,380 | 0 to 260.4 K |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | Vivo Capital VIII, LLC | 10% Owner | Buy | C | 0.00 | 224,054 | 0 | 2,633,391 | 2.4 M to 2.6 M (+9.30 %) |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | Vivo Capital VIII, LLC | 10% Owner | Buy | C | 0.00 | 523,726 | 0 | 2,409,337 | 1.9 M to 2.4 M (+27.77 %) |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | Vivo Capital VIII, LLC | 10% Owner | Buy | C | 0.00 | 1,885,611 | 0 | 1,885,611 | 0 to 1.9 M |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | Versant Venture Capital VI, L. ... | 10% Owner | Option Exercise | C | 0.00 | 198,485 | 0 | 0 | |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | Versant Venture Capital VI, L. ... | 10% Owner | Option Exercise | C | 0.00 | 85,065 | 0 | 0 | |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | Versant Venture Capital VI, L. ... | 10% Owner | Option Exercise | C | 0.00 | 463,959 | 0 | 0 | |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | Versant Venture Capital VI, L. ... | 10% Owner | Option Exercise | C | 0.00 | 198,839 | 0 | 0 | |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | Versant Venture Capital VI, L. ... | 10% Owner | Option Exercise | C | 0.00 | 2,145,991 | 0 | 0 | |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | Versant Venture Capital VI, L. ... | 10% Owner | Buy | P | 15.00 | 200,000 | 3,000,000 | 862,444 | 662.4 K to 862.4 K (+30.19 %) |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | Versant Venture Capital VI, L. ... | 10% Owner | Buy | C | 0.00 | 198,485 | 0 | 662,444 | 464 K to 662.4 K (+42.78 %) |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | Versant Venture Capital VI, L. ... | 10% Owner | Buy | C | 0.00 | 463,959 | 0 | 463,959 | 0 to 464 K |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | Versant Venture Capital VI, L. ... | 10% Owner | Buy | C | 0.00 | 85,065 | 0 | 2,429,895 | 2.3 M to 2.4 M (+3.63 %) |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | Versant Venture Capital VI, L. ... | 10% Owner | Buy | C | 0.00 | 198,839 | 0 | 2,344,830 | 2.1 M to 2.3 M (+9.27 %) |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | Versant Venture Capital VI, L. ... | 10% Owner | Buy | C | 0.00 | 2,145,991 | 0 | 2,145,991 | 0 to 2.1 M |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | Symons Julian A. | See Remarks | Option Exercise | C | 0.00 | 1,452 | 0 | 0 | |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | Symons Julian A. | See Remarks | Option Exercise | C | 0.00 | 3,394 | 0 | 0 | |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | Symons Julian A. | See Remarks | Option Exercise | C | 0.00 | 13,671 | 0 | 0 | |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | Symons Julian A. | See Remarks | Buy | C | 0.00 | 1,452 | 0 | 394,064 | 392.6 K to 394.1 K (+0.37 %) |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | Symons Julian A. | See Remarks | Buy | C | 0.00 | 3,394 | 0 | 392,612 | 389.2 K to 392.6 K (+0.87 %) |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | Symons Julian A. | See Remarks | Buy | C | 0.00 | 13,671 | 0 | 389,218 | 375.5 K to 389.2 K (+3.64 %) |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | Quan Lucinda Y. | See Remarks | Option Exercise | C | 0.00 | 726 | 0 | 0 | |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | Quan Lucinda Y. | See Remarks | Option Exercise | C | 0.00 | 1,697 | 0 | 0 | |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | Quan Lucinda Y. | See Remarks | Option Exercise | C | 0.00 | 6,835 | 0 | 0 | |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | Quan Lucinda Y. | See Remarks | Buy | C | 0.00 | 726 | 0 | 9,258 | 8.5 K to 9.3 K (+8.51 %) |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | Quan Lucinda Y. | See Remarks | Buy | C | 0.00 | 1,697 | 0 | 8,532 | 6.8 K to 8.5 K (+24.83 %) |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | Quan Lucinda Y. | See Remarks | Buy | C | 0.00 | 6,835 | 0 | 6,835 | 0 to 6.8 K |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | Nuechterlein Carole | Director | Option Exercise | C | 0.00 | 283,550 | 0 | 0 | |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | Nuechterlein Carole | Director | Option Exercise | C | 0.00 | 662,799 | 0 | 0 | |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | Nuechterlein Carole | Director | Option Exercise | C | 0.00 | 2,145,991 | 0 | 0 | |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | Nuechterlein Carole | Director | Buy | C | 0.00 | 283,550 | 0 | 3,092,340 | 2.8 M to 3.1 M (+10.10 %) |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | Nuechterlein Carole | Director | Buy | C | 0.00 | 662,799 | 0 | 2,808,790 | 2.1 M to 2.8 M (+30.89 %) |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | Nuechterlein Carole | Director | Buy | C | 0.00 | 2,145,991 | 0 | 2,145,991 | 0 to 2.1 M |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | BLATT LAWRENCE | Chief Executive Off ... | Option Exercise | C | 0.00 | 1,452 | 0 | 0 | |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | BLATT LAWRENCE | Chief Executive Off ... | Option Exercise | C | 0.00 | 1,452 | 0 | 0 | |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | BLATT LAWRENCE | Chief Executive Off ... | Option Exercise | C | 0.00 | 21,695 | 0 | 0 | |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | BLATT LAWRENCE | Chief Executive Off ... | Option Exercise | C | 0.00 | 3,394 | 0 | 0 | |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | BLATT LAWRENCE | Chief Executive Off ... | Option Exercise | C | 0.00 | 3,394 | 0 | 0 | |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | BLATT LAWRENCE | Chief Executive Off ... | Option Exercise | C | 0.00 | 50,712 | 0 | 0 | |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | BLATT LAWRENCE | Chief Executive Off ... | Option Exercise | C | 0.00 | 13,671 | 0 | 0 | |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | BLATT LAWRENCE | Chief Executive Off ... | Option Exercise | C | 0.00 | 13,671 | 0 | 0 | |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | BLATT LAWRENCE | Chief Executive Off ... | Option Exercise | C | 0.00 | 122,601 | 0 | 0 | |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | BLATT LAWRENCE | Chief Executive Off ... | Option Exercise | C | 0.00 | 41,016 | 0 | 0 | |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | BLATT LAWRENCE | Chief Executive Off ... | Buy | C | 0.00 | 1,452 | 0 | 18,517 | 17.1 K to 18.5 K (+8.51 %) |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | BLATT LAWRENCE | Chief Executive Off ... | Buy | C | 0.00 | 1,452 | 0 | 18,517 | 17.1 K to 18.5 K (+8.51 %) |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | BLATT LAWRENCE | Chief Executive Off ... | Buy | C | 0.00 | 21,695 | 0 | 113,423 | 91.7 K to 113.4 K (+23.65 %) |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | BLATT LAWRENCE | Chief Executive Off ... | Buy | C | 0.00 | 3,394 | 0 | 17,065 | 13.7 K to 17.1 K (+24.83 %) |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | BLATT LAWRENCE | Chief Executive Off ... | Buy | C | 0.00 | 3,394 | 0 | 17,065 | 13.7 K to 17.1 K (+24.83 %) |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | BLATT LAWRENCE | Chief Executive Off ... | Buy | C | 0.00 | 50,712 | 0 | 91,728 | 41 K to 91.7 K (+123.64 %) |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | BLATT LAWRENCE | Chief Executive Off ... | Buy | C | 0.00 | 13,671 | 0 | 13,671 | 0 to 13.7 K |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | BLATT LAWRENCE | Chief Executive Off ... | Buy | C | 0.00 | 13,671 | 0 | 13,671 | 0 to 13.7 K |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | BLATT LAWRENCE | Chief Executive Off ... | Buy | C | 0.00 | 122,601 | 0 | 122,601 | 0 to 122.6 K |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | BLATT LAWRENCE | Chief Executive Off ... | Buy | C | 0.00 | 41,016 | 0 | 41,016 | 0 to 41 K |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | Beigelman Leonid | President | Option Exercise | C | 0.00 | 1,437 | 0 | 0 | |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | Beigelman Leonid | President | Option Exercise | C | 0.00 | 1,437 | 0 | 0 | |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | Beigelman Leonid | President | Option Exercise | C | 0.00 | 21,724 | 0 | 0 | |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | Beigelman Leonid | President | Option Exercise | C | 0.00 | 3,359 | 0 | 0 | |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | Beigelman Leonid | President | Option Exercise | C | 0.00 | 3,359 | 0 | 0 | |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | Beigelman Leonid | President | Option Exercise | C | 0.00 | 50,781 | 0 | 0 | |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | Beigelman Leonid | President | Option Exercise | C | 0.00 | 13,559 | 0 | 0 | |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | Beigelman Leonid | President | Option Exercise | C | 0.00 | 13,559 | 0 | 0 | |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | Beigelman Leonid | President | Option Exercise | C | 0.00 | 163,842 | 0 | 0 | |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | Beigelman Leonid | President | Buy | C | 0.00 | 1,437 | 0 | 18,355 | 16.9 K to 18.4 K (+8.49 %) |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | Beigelman Leonid | President | Buy | C | 0.00 | 1,437 | 0 | 18,355 | 16.9 K to 18.4 K (+8.49 %) |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | Beigelman Leonid | President | Buy | C | 0.00 | 21,724 | 0 | 236,347 | 214.6 K to 236.3 K (+10.12 %) |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | Beigelman Leonid | President | Buy | C | 0.00 | 3,359 | 0 | 16,918 | 13.6 K to 16.9 K (+24.77 %) |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | Beigelman Leonid | President | Buy | C | 0.00 | 3,359 | 0 | 16,918 | 13.6 K to 16.9 K (+24.77 %) |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | Beigelman Leonid | President | Buy | C | 0.00 | 50,781 | 0 | 214,623 | 163.8 K to 214.6 K (+30.99 %) |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | Beigelman Leonid | President | Buy | C | 0.00 | 13,559 | 0 | 13,559 | 0 to 13.6 K |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | Beigelman Leonid | President | Buy | C | 0.00 | 13,559 | 0 | 13,559 | 0 to 13.6 K |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | Beigelman Leonid | President | Buy | C | 0.00 | 163,842 | 0 | 163,842 | 0 to 163.8 K |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | Beigelman Leonid | President | Option Exercise | C | 0.00 | 1,437 | 0 | 0 | |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | Beigelman Leonid | President | Option Exercise | C | 0.00 | 1,437 | 0 | 0 | |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | Beigelman Leonid | President | Option Exercise | C | 0.00 | 21,724 | 0 | 0 | |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | Beigelman Leonid | President | Option Exercise | C | 0.00 | 3,359 | 0 | 0 | |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | Beigelman Leonid | President | Option Exercise | C | 0.00 | 3,359 | 0 | 0 | |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | Beigelman Leonid | President | Option Exercise | C | 0.00 | 50,781 | 0 | 0 | |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | Beigelman Leonid | President | Option Exercise | C | 0.00 | 13,559 | 0 | 0 | |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | Beigelman Leonid | President | Option Exercise | C | 0.00 | 13,559 | 0 | 0 | |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | Beigelman Leonid | President | Option Exercise | C | 0.00 | 163,842 | 0 | 0 | |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | Beigelman Leonid | President | Buy | C | 0.00 | 1,437 | 0 | 18,355 | 16.9 K to 18.4 K (+8.49 %) |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | Beigelman Leonid | President | Buy | C | 0.00 | 1,437 | 0 | 18,355 | 16.9 K to 18.4 K (+8.49 %) |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | Beigelman Leonid | President | Buy | C | 0.00 | 21,724 | 0 | 236,347 | 214.6 K to 236.3 K (+10.12 %) |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | Beigelman Leonid | President | Buy | C | 0.00 | 3,359 | 0 | 16,918 | 13.6 K to 16.9 K (+24.77 %) |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | Beigelman Leonid | President | Buy | C | 0.00 | 3,359 | 0 | 16,918 | 13.6 K to 16.9 K (+24.77 %) |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | Beigelman Leonid | President | Buy | C | 0.00 | 50,781 | 0 | 214,623 | 163.8 K to 214.6 K (+30.99 %) |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | Beigelman Leonid | President | Buy | C | 0.00 | 13,559 | 0 | 13,559 | 0 to 13.6 K |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | Beigelman Leonid | President | Buy | C | 0.00 | 13,559 | 0 | 13,559 | 0 to 13.6 K |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | Beigelman Leonid | President | Buy | C | 0.00 | 163,842 | 0 | 163,842 | 0 to 163.8 K |
Page: 1